Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

被引:3921
作者
Calin, GA
Dumitru, CD
Shimizu, M
Bichi, R
Zupo, S
Noch, E
Aldler, H
Rattan, S
Keating, M
Rai, K
Rassenti, L
Kipps, T
Negrini, M
Bullrich, F
Croce, CM
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Natl Inst Canc Res, I-16132 Genoa, Italy
关键词
D O I
10.1073/pnas.242606799
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Micro-RNAs (miR genes) are a large family of highly conserved noncoding genes thought to be involved in temporal and tissue-specific gene regulation. MiRs are transcribed as short hairpin precursors (approximate to70 nt) and are processed into active 21- to 22-nt RNAs by Dicer, a ribonuclease that recognizes target mRNAs via base-pairing interactions. Here we show that miR15 and miR16 are located at chromosome 13q14, a region deleted in more than half of B cell chronic lymphocytic leukemias (B-CLL). Detailed deletion and expression analysis shows that miR15 and miR16 are located within a 30-kb region of loss in CLL, and that both genes are deleted or down-regulated in the majority (approximate to68%) of CLL cases.
引用
收藏
页码:15524 / 15529
页数:6
相关论文
共 39 条
[1]   microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[2]  
[Anonymous], 2001, BASIC CLIN ONCOL
[3]   Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3 [J].
BouygeMoreau, I ;
Rondeau, G ;
AvetLoiseau, H ;
Andre, MT ;
Bezieau, S ;
Cherel, M ;
Saleun, S ;
Cadoret, E ;
Shaikh, T ;
DeAngelis, MM ;
Arcot, S ;
Batzer, M ;
Moisan, JP ;
Devilder, MC .
GENOMICS, 1997, 46 (02) :183-190
[4]   Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia [J].
Bullrich, F ;
Veronese, ML ;
Kitada, S ;
Jurlander, J ;
Caligiuri, MA ;
Reed, JC ;
Croce, CM .
BLOOD, 1996, 88 (08) :3109-3115
[5]  
Bullrich F, 2001, CANCER RES, V61, P6640
[6]   B-cell chronic lymphocytic leukemia: A bird of a different feather [J].
Caligaris-Cappio, F ;
Hamblin, TJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :399-408
[7]   Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia [J].
Corcoran, MM ;
Rasool, O ;
Liu, Y ;
Iyengar, A ;
Grander, D ;
Ibbotson, RE ;
Merup, M ;
Wu, XS ;
Brodyansky, V ;
Gardiner, AC ;
Juliusson, G ;
Chapman, RM ;
Ivanova, G ;
Tiller, M ;
Gahrton, G ;
Yankovsky, N ;
Zabarovsky, E ;
Oscier, DG ;
Einhorn, S .
BLOOD, 1998, 91 (04) :1382-1390
[8]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[9]   Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer [J].
Dong, JT ;
Boyd, JC ;
Frierson, HF .
PROSTATE, 2001, 49 (03) :166-171
[10]   Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents [J].
Dono, M ;
Zupo, S ;
Leanza, N ;
Melioli, G ;
Fogli, M ;
Melagrana, A ;
Chiorazzi, N ;
Ferrarini, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5596-5604